BTK inhibitor approved based on results from two phase III trials

“Consider a new route”Neil Snowise, visiting senior lecturer at the Institute of Pharmaceutical Science at King’s College, London, […]

The surname of Alessandra Borsini was misspelt in the author list of this article by Joseph Firth and […]

GlaxoSmithKline’s HIV PrEP challenge looms as ViiV’s long-acting drug tops Gilead’s Truvada in women aliu Mon, 11/09/2020 – […]

Fierce Pharma Politics—Biden puts COVID-19 transition task force on the job esagonowsky Mon, 11/09/2020 – 09:15

Ironwood names proxy brawler Denner to its board a year after R&D spinoff kblankenship Mon, 11/09/2020 – 09:51

FDA reputation takes another hit after scathing aducanumab advisory panel meeting bbulik Mon, 11/09/2020 – 10:50

After Pfizer’s vaccine data, analysts say COVID drug makers face questions about long-term sales prospects esagonowsky Mon, 11/09/2020 […]

Phase III study of vaccine candidate involved 43,538 participants

In the quest to image exceedingly small structures and phenomenon with higher precision, scientists have been pushing the […]